09/25/2012—Recently a Yaz Lawsuit was filed in the Southern District of Illinois by Plaintiff Alexis Carrier, by a Yaz Lawyer representing the plaintiff. The plaintiff has brought this Yaz Lawsuit in the ongoing Yaz Multi District Litigation because of a deep vein thrombosis injury that she suffered in or about October 11, 2011. She alleges that her injuries were caused by the Defendants in this Yaz Lawsuit, and that her injuries were severe and permanent.
The Yaz Lawsuit that was recently filed was filed within the current Multi-District Litigation Action pending within the Southern District of Illinois. This Multi-District Litigation action includes claims for injuries against the manufacturers of Yaz, Yasmin and Ocella. The Plaintiff was able to file her Yaz Lawusit within this Multi District Litigation Action because she took Yasmin and Ocella between May 2006 and October 2011 and her injuries are allegedly correlated to her use of these drugs. This multi-district litigation action differs from a Yaz Class Action Lawsuit. In the Yaz MDL or Multi-district Litgation each separate Yaz lawsuit filed across the country will be consolidated into this one court and addressed by this one appointed judge.
Plaintiff alleges that Defendants owed a duty to exercise reasonable care in the design, manufacture, testing, marketing, distributing, sale, and/or post-sale surveillance of Yasmin and Ocella. Plaintiff further alleges that Defendants failed to exercise ordinary care in the design, formulation, manufacture, testing, quality assurance, quality control, distribution, marketing, sale, and/or post-sale surveillance of Defendants’ Yasmin and Ocella in that Defendants knew or should have known that Defendants’ Yasmin and Ocella could cause such significant bodily harm and death and were not safe for administration to consumers. Plaintiff states that despite the fact that Defendants knew or should have known that Defendants’ Yasmin and Ocella posed a serious risk of bodily harm to consumers, Defendants continued to manufacture and market Defendants’ Yasmin and Ocella for administration to patients. Both the Yaz and Yasmin Lawsuit are combined in the Illinois MDL
Plaintiff states that Defendants did not adequately warn consumers of the risks associated with use of Yasmin and Ocella. She asserts that had she or her medical care providers known of the high level of risk associated with use of Yasmin and Ocella she never would have been injured because she would not have taken these drugs in the first place.
For more information on the Yaz and Yasmin Lawsuits or to arrange a free legal consultation please contact us toll free at 800-611-7080 or via our contact form on this page.